Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Avacta Group Fundamentals

Company Name Avacta Group Last Updated 06 Aug 2020
Industry Health Care Sector Biotechnology
Shares in Issue (m) 249.16 Market Cap (£m) 333.87
PE Ratio -10.32 Div per Share () 0.00
Div Yield 0.00 Div Cover 0.00
EPS -12.98 EPS Growth (%) -48.17
PEG 0.21 DPS Growth (%) n/a
Debt Ratio 0.00 Debt Equity Ratio 0.00
Net Gearing -16.40 Gross Gearing 8.90
Asset Equity Ratio 1.10 Cash Equity Ratio 27.77
Quick Ratio 4.53 Current Ratio 4.61
Price To Book Value 14.24 ROCE -47.48

Avacta Group Dividends

Type Ex-Date Pay Date Currency Net Dividend Year Total

Avacta Group Company Financials

Assets (£m) 2019 2019 2018
Tangible Assets 3 3 3
Intangible Assets 13 13 12
Investments 0 0 0
Total Fixed Assets 15 15 15
Stocks 0 0 0
Debtors 2 2 1
Cash & Equivalents 7 7 5
Other Assets 2 2 2
Total Assets 26 26 23
Liabilities (£m) 2019 2019 2018
Creditors within 1 year 2 2 2
Creditors after 1 year 0 0 0
Other Liabilities 0 0 0
Total Liabilities 2 2 2
Net assets 23 23 21
Equity (£m) 2019 2019 2018
Called up share capital 12 12 7
Share Premium 7 7 1
Profit / Loss -11 -11 -10
Other Equity -3 -3 -3
Preference & Minorities 0 0 0
Total Capital Employed 23 23 21
Ratios 2019 2019 2018
Debt Ratio 0.00 0.00 0.00
Debt-to-Equity 0.00 0.00 0.00
Net Gearing -16.40 -16.40 -13.56
Gross Gearing 8.90 8.90 8.70
Assets / Equity 1.10 1.10 1.10
Cash / Equity 27.77 27.77 24.38
EPS -8.76 -8.76 -13.49
Cash Flow (£m) 2019 2019 2018
Cash from operating activities -8 -8 -5
Cashflow before financing -10 -10 -4
Increase in Cash 1 1 -4
Income (£m) 2019 2019 2018
Turnover 4 4 3
Cost of sales 1 1 1
Gross Profit 3 3 2
Operating Profit -11 -11 -10
Pre-Tax profit -11 -11 -10
Profit / Loss for the year 12 12 7

Avacta Group Company Background

Sector Biotechnology
Activities Avacta Group plc's (formerly Readybuy plc) principal focus is on its proprietary Affimer technology which is a novel engineered alternative to antibodies that has wide application in Life Sciences for diagnostics, therapeutics and general research and development. Antibodies dominate markets worth in excess of $100bn despite their shortcomings. Affimer technology has been designed to address many of these negative performance issues, principally; the time taken to generate new antibodies, the reliance on an animal's immune response, poor specificity in many cases, and batch to batch variability. Affimer technology is based on a small protein that can be quickly generated to bind with high specificity and affinity to a wide range of protein targets. Avacta has a pre-clinical biotech development programme with an in-house focus on immuno-oncology as well as partnered development programmes. Avacta is commercialising non-therapeutic Affimer reagents through licensing to developers of life sciences research tools and diagnostics.
Latest Interim Date 09 Apr 2019
Latest Fiscal Year End Date 06 May 2020

Avacta Group Directors

Appointed Director Position
2006-07-07 Prof David Alastair Maclaughlin Smith Chief Executive Officer
2016-01-04 Tony Peter Gardiner Chief Financial Officer
2018-06-11 Dr Eliot Richard Forster Non-Executive Chairman
2020-02-03 Paul Andrew Fry Non-Executive Director
2015-09-17 Dr Michael John Owen Non-Executive Director
2013-08-05 Dr Trevor John Nicholls Non-Executive Director

Avacta Group Contact Details

Company Name Avacta Group
Company Address Unit 20, Ash Way, Thorp Arch Estate, Wetherby LS23 7FA.
Company Telephone +44 (0)844 414 0452
Company Website http://www.avacta.com/

Avacta Group Advisors

Auditor Name KPMG Audit
Auditor Address 1 The Embankment, Neville Street, Leeds LS1 4DW.
Auditor Website http://www.kpmg.com/
Auditor Telephone +44 (0)113 231 3000
Registrar Name Link Asset Services
Registrar Address The Registry, 34 Beckenham Road, Beckenham, Kent BR3 4TU.
Registrar Website http://www.linkassetservices.com/
Registrar Telephone 0870 162 3100
Broker Name finnCap
Broker Address 60 New Broad Street
Broker Website http://www.finncap.com/
Broker Telephone +44 (0)207 220 0500
Adviser Name finnCap
Adviser Address 60 New Broad Street
Adviser Website http://www.finncap.com/
Adviser Telephone +44 (0)207 220 0500
Solicitor Name Walker Morris
Solicitor Address Kings Court, 12 King Street, Leeds, LS1 2HL.
Solicitor Website http://www.walkermorris.co.uk/
Solicitor Telephone +44 (0)113 283 2500
Stockbroker Name WG Partners
Stockbroker Address 85 Gresham Street, London EC2V 7NQ.
Stockbroker Website http://www.wgpartners.co.uk/
Stockbroker Telephone +44 (0)203 705 9318